Response to "Lactation status and studies of pyrimethamine pharmacokinetics in pregnancy". by de Kock, M, Tarning, J, Barnes, K, Denti, P

Pharmacokinetics of sulfadoxine and pyrimethamine for intermittent preventive treatment of malaria during pregnancy and after delivery by de Kock, M, Tarning, J, Workman, L, Nyunt, M, Adam, I, Barnes, K, Denti, P

Population pharmacokinetic properties of sulfadoxine and pyrimethamine: a pooled analysis to inform optimal dosing in African children with uncomplicated malaria by de Kock, M, Tarning, J, Workman, L, Allen, EN, Tekete, MM, Djimde, AA, Bell, DJ, Ward, SA, Barnes, KI, Denti, P

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, van der Merwe, L, de Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, Van Der Merwe, L, De Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. by Scriba, T, Tameris, M, Mansoor, N, Smit, E, van der Merwe, L, Mauff, K, Hughes, E, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hussey, G, Mahomed, H, Hanekom, W, Mcshane, H

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. by Scriba, T, Tameris, M, Smit, E, van der Merwe, L, Hughes, E, Kadira, B, Mauff, K, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Makhethe, L, Janse van Rensburg, E, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hawkridge, A, Hussey, G, Hanekom, W, McShane, H, Mahomed, H